{"id":55212,"date":"2023-03-27T15:07:32","date_gmt":"2023-03-27T13:07:32","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/femdx-medsystems-inc-receives-fda-clearance-for-its-falloview-falloposcope\/"},"modified":"2023-03-27T15:07:32","modified_gmt":"2023-03-27T13:07:32","slug":"femdx-medsystems-inc-receives-fda-clearance-for-its-falloview-falloposcope","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/femdx-medsystems-inc-receives-fda-clearance-for-its-falloview-falloposcope\/","title":{"rendered":"FemDx Medsystems, Inc. Receives FDA Clearance For Its FalloView\u2122 Falloposcope"},"content":{"rendered":"
\n

\nThe smallest disposable CMOS endoscope to receive clearance by the FDA<\/b>\n<\/p>\n

SANTA CLARA, Calif.–(BUSINESS WIRE)–FemDx Medsystems, Inc., a women\u2019s health startup based in Santa Clara, CA announces the company has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its FalloView\u2122 device. According to Ashlee Francis, CEO of FemDx Medsystems, Inc., the device is the first totally disposable 1.2mm diameter falloposcope incorporating a CMOS chip endoscope to evaluate the proximal fallopian tube in a non-invasive fashion. The FalloView\u2122 falloposcope has a self-contained light source and video monitor powered by a 9 volt battery, providing the gynecologist with untethered access to the patient\u2019s uterus and fallopian tubes without the traditional constraints of remote video imaging and the weight of attached camera cable and light cord associated with conventional instrumentation. The LCD screen on the handle of the device allows the physician to visualize internal patient anatomy in line with instrument insertion.\n<\/p>\n

<\/a><\/p>\n

\nIn addition, Albert K. Chin, M.D., Chief Innovation Officer of FemDx Medsystems, Inc. states that the company\u2019s first patent, associated with the method of use of the device, has been issued by the U.S. Patent and Trademark Office last week. Multiple patent applications have been filed on additional designs and devices. Albert K. Chin is the author of 227 issued U.S. patents.\n<\/p>\n

\nPei-Jie Cao, Ph.D., CTO of FemDx Medsystems, Inc. is developing subsequent devices to address additional critical issues in women\u2019s health; for example, improved instrumentation to facilitate uterine fibroid ablation and resection. The collective development of novel diagnostic and therapeutic instrumentation will positively advance underserved segments in women\u2019s health initiatives.\n<\/p>\n

\nFemDx Medsystems, Inc. is funded by ShangBay Capital, SV Tech Ventures, and well-known venture investors from Silicon Valley. ShangBay Capital is a leading medical technology-focused venture firm based in Palo Alto, California. The fund has invested in 62 companies and has had multiple successful exits to date.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nXi Ashlee Francis
\n
ashlee@femdxmedical.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

The smallest disposable CMOS endoscope to receive clearance by the FDA SANTA CLARA, Calif.–(BUSINESS WIRE)–FemDx Medsystems, Inc., a women\u2019s health startup based in Santa Clara, CA announces the company has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its FalloView\u2122 device. According to Ashlee Francis, CEO of FemDx Medsystems, Inc., the device is … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-55212","6":"format-standard","7":"category-industry"},"yoast_head":"\nFemDx Medsystems, Inc. Receives FDA Clearance For Its FalloView\u2122 Falloposcope - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/femdx-medsystems-inc-receives-fda-clearance-for-its-falloview-falloposcope\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FemDx Medsystems, Inc. Receives FDA Clearance For Its FalloView\u2122 Falloposcope - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"The smallest disposable CMOS endoscope to receive clearance by the FDA SANTA CLARA, Calif.–(BUSINESS WIRE)–FemDx Medsystems, Inc., a women\u2019s health startup based in Santa Clara, CA announces the company has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its FalloView\u2122 device. According to Ashlee Francis, CEO of FemDx Medsystems, Inc., the device is ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/femdx-medsystems-inc-receives-fda-clearance-for-its-falloview-falloposcope\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-27T13:07:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230323005767\/en\/1747527\/21\/femdx_medsystems.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/femdx-medsystems-inc-receives-fda-clearance-for-its-falloview-falloposcope\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/femdx-medsystems-inc-receives-fda-clearance-for-its-falloview-falloposcope\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"FemDx Medsystems, Inc. Receives FDA Clearance For Its FalloView\u2122 Falloposcope\",\"datePublished\":\"2023-03-27T13:07:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/femdx-medsystems-inc-receives-fda-clearance-for-its-falloview-falloposcope\\\/\"},\"wordCount\":336,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/femdx-medsystems-inc-receives-fda-clearance-for-its-falloview-falloposcope\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230323005767\\\/en\\\/1747527\\\/21\\\/femdx_medsystems.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/femdx-medsystems-inc-receives-fda-clearance-for-its-falloview-falloposcope\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/femdx-medsystems-inc-receives-fda-clearance-for-its-falloview-falloposcope\\\/\",\"name\":\"FemDx Medsystems, Inc. Receives FDA Clearance For Its FalloView\u2122 Falloposcope - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/femdx-medsystems-inc-receives-fda-clearance-for-its-falloview-falloposcope\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/femdx-medsystems-inc-receives-fda-clearance-for-its-falloview-falloposcope\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230323005767\\\/en\\\/1747527\\\/21\\\/femdx_medsystems.jpg\",\"datePublished\":\"2023-03-27T13:07:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/femdx-medsystems-inc-receives-fda-clearance-for-its-falloview-falloposcope\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/femdx-medsystems-inc-receives-fda-clearance-for-its-falloview-falloposcope\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/femdx-medsystems-inc-receives-fda-clearance-for-its-falloview-falloposcope\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230323005767\\\/en\\\/1747527\\\/21\\\/femdx_medsystems.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230323005767\\\/en\\\/1747527\\\/21\\\/femdx_medsystems.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/femdx-medsystems-inc-receives-fda-clearance-for-its-falloview-falloposcope\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FemDx Medsystems, Inc. Receives FDA Clearance For Its FalloView\u2122 Falloposcope\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FemDx Medsystems, Inc. Receives FDA Clearance For Its FalloView\u2122 Falloposcope - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/femdx-medsystems-inc-receives-fda-clearance-for-its-falloview-falloposcope\/","og_locale":"en_US","og_type":"article","og_title":"FemDx Medsystems, Inc. Receives FDA Clearance For Its FalloView\u2122 Falloposcope - Pharma Trend","og_description":"The smallest disposable CMOS endoscope to receive clearance by the FDA SANTA CLARA, Calif.–(BUSINESS WIRE)–FemDx Medsystems, Inc., a women\u2019s health startup based in Santa Clara, CA announces the company has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its FalloView\u2122 device. According to Ashlee Francis, CEO of FemDx Medsystems, Inc., the device is ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/femdx-medsystems-inc-receives-fda-clearance-for-its-falloview-falloposcope\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-27T13:07:32+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230323005767\/en\/1747527\/21\/femdx_medsystems.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/femdx-medsystems-inc-receives-fda-clearance-for-its-falloview-falloposcope\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/femdx-medsystems-inc-receives-fda-clearance-for-its-falloview-falloposcope\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"FemDx Medsystems, Inc. Receives FDA Clearance For Its FalloView\u2122 Falloposcope","datePublished":"2023-03-27T13:07:32+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/femdx-medsystems-inc-receives-fda-clearance-for-its-falloview-falloposcope\/"},"wordCount":336,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/femdx-medsystems-inc-receives-fda-clearance-for-its-falloview-falloposcope\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230323005767\/en\/1747527\/21\/femdx_medsystems.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/femdx-medsystems-inc-receives-fda-clearance-for-its-falloview-falloposcope\/","url":"https:\/\/pharma-trend.com\/en\/femdx-medsystems-inc-receives-fda-clearance-for-its-falloview-falloposcope\/","name":"FemDx Medsystems, Inc. Receives FDA Clearance For Its FalloView\u2122 Falloposcope - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/femdx-medsystems-inc-receives-fda-clearance-for-its-falloview-falloposcope\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/femdx-medsystems-inc-receives-fda-clearance-for-its-falloview-falloposcope\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230323005767\/en\/1747527\/21\/femdx_medsystems.jpg","datePublished":"2023-03-27T13:07:32+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/femdx-medsystems-inc-receives-fda-clearance-for-its-falloview-falloposcope\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/femdx-medsystems-inc-receives-fda-clearance-for-its-falloview-falloposcope\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/femdx-medsystems-inc-receives-fda-clearance-for-its-falloview-falloposcope\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230323005767\/en\/1747527\/21\/femdx_medsystems.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230323005767\/en\/1747527\/21\/femdx_medsystems.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/femdx-medsystems-inc-receives-fda-clearance-for-its-falloview-falloposcope\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"FemDx Medsystems, Inc. Receives FDA Clearance For Its FalloView\u2122 Falloposcope"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55212","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=55212"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55212\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=55212"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=55212"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=55212"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}